Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13™ in PPSV23-vaccinated Healthy Adults ≥65 Years of Age (V114-007)
Clinical trial NCT02573181 · COMPLETED
Trial details
- NCT number
- NCT02573181
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-30
- Primary completion
- 2016-01-28
- Enrollment
- 253
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.